Humacyte Stock Technical Analysis

HUMAW Stock  USD 1.69  0.11  6.96%   
As of the 23rd of November, Humacyte retains the Market Risk Adjusted Performance of (0.07), standard deviation of 7.05, and Risk Adjusted Performance of 0.0029. Humacyte technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Humacyte variance and potential upside to decide if Humacyte is priced fairly, providing market reflects its last-minute price of 1.69 per share. Please also validate Humacyte jensen alpha, which is currently at (0.17) to confirm the company can sustain itself at a future point.

Humacyte Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Humacyte, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Humacyte
  
Humacyte's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Humacyte technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Humacyte technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Humacyte trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Humacyte Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Humacyte volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Humacyte Trend Analysis

Use this graph to draw trend lines for Humacyte. You can use it to identify possible trend reversals for Humacyte as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Humacyte price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Humacyte Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Humacyte applied against its price change over selected period. The best fit line has a slop of    , which means Humacyte will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.08, which is the sum of squared deviations for the predicted Humacyte price change compared to its average price change.

About Humacyte Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Humacyte on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Humacyte based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Humacyte price pattern first instead of the macroeconomic environment surrounding Humacyte. By analyzing Humacyte's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Humacyte's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Humacyte specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2022 2023 2024 (projected)
Graham Number8.043.991.781.69
Receivables Turnover7.1850.4845.4447.71

Humacyte November 23, 2024 Technical Indicators

Most technical analysis of Humacyte help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Humacyte from various momentum indicators to cycle indicators. When you analyze Humacyte charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Additional Tools for Humacyte Stock Analysis

When running Humacyte's price analysis, check to measure Humacyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humacyte is operating at the current time. Most of Humacyte's value examination focuses on studying past and present price action to predict the probability of Humacyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humacyte's price. Additionally, you may evaluate how the addition of Humacyte to your portfolios can decrease your overall portfolio volatility.